iBio (IBIO) Notes Payables (2020 - 2025)
iBio (IBIO) posted Notes Payables of $706,000 for fiscal Q1 2026 (quarter ended Sep 30, 2025), up 211.0% from $227,000 a year earlier but down 7.8% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Notes Payables (2020 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), iBio's Notes Payables came in at $766,000, up 251.4% from FY2024.
- Annual Notes Payables shows a five-year compound annual growth rate of 24.0% (FY2020 to FY2025).
- In prior fiscal years, iBio's Notes Payables was $218,000 in FY2024 (-98.3%), $12.94 million in FY2023 (-41.6%), $22.16 million in FY2022 and $600,000 in FY2021 (+129.9%).
- Quarterly Notes Payables has run from a low of $218,000 in fiscal Q4 2024 to a high of $22.2 million in fiscal Q1 2023 over five years.
- On a year-over-year basis, Notes Payables increased in two of the last eight quarters, with growth averaging 6.1%.
- The strongest year-over-year quarter for Notes Payables in the past five years was fiscal Q4 2025, with growth of 251.4%; the weakest was fiscal Q4 2024, with a decline of 98.3%.
- According to Business Quant data, Notes Payables for the three prior fiscal quarters was $766,000 (Q4 2025), $824,000 (Q3 2025) and $601,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 706,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Mar 31, 2025 | 824,000.00 |
| Dec 31, 2024 | 601,000.00 |
| Sep 30, 2024 | 227,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 12.66 Mn |
| Dec 31, 2023 | 12.66 Mn |
| Sep 30, 2023 | 12.63 Mn |
| Jun 30, 2023 | 12.94 Mn |
| Mar 31, 2023 | 13.70 Mn |
| Dec 31, 2022 | 16.01 Mn |
| Sep 30, 2022 | 22.20 Mn |
| Jun 30, 2022 | 22.16 Mn |
| Jun 30, 2021 | 600,000.00 |
| Mar 31, 2021 | 566,000.00 |
| Dec 31, 2020 | 465,000.00 |
| Sep 30, 2020 | 362,000.00 |
| Jun 30, 2020 | 261,000.00 |
| Mar 31, 2020 | 1.20 Mn |
API Access
iBio Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();